本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kymera Therapeutics, Inc.

82.07
-2.1200-2.52%
盘后82.070.00000.00%16:10 EST
成交量:110.31万
成交额:9,069.94万
市值:65.48亿
市盈率:-22.81
高:84.23
开:83.36
低:80.78
收:84.19
52周最高:103.00
52周最低:19.45
股本:7,979.12万
流通股本:5,462.66万
量比:0.56
换手率:2.02%
股息:- -
股息率:- -
每股收益(TTM):-3.5975
每股收益(LYR):-2.9830
净资产收益率:-32.09%
总资产收益率:-19.21%
市净率:6.92
市盈率(LYR):-27.51

数据加载中...

2025/12/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/10

重要事件披露

Form 8-K - Current report
2025/12/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/08

重要事件披露

Form 8-K - Current report
2025/12/08

重要事件披露

Form 8-K - Current report
2025/11/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/04

重要事件披露

Form 8-K - Current report
2025/10/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities